Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, USA.
J Clin Psychiatry. 2013 Jun;74(6):e12. doi: 10.4088/JCP.12045tx2c.
Although effective treatments for negative symptoms are currently limited, clinicians still need to assess and monitor them because of their impact on patient functioning. Further, documenting patients' negative symptoms provides a complete clinical record that the clinician can use to make systematic and careful treatment decisions. Several tools for assessing negative symptoms in schizophrenia are available, including the Clinical Global Impression scale (CGI), the Brief Psychiatric Rating Scale (BPRS), the Positive and Negative Syndrome Scale (PANSS), the Scale for the Assessment of Negative Symptoms (SANS), the 16-item Negative Symptoms Assessment (NSA-16), and the Schedule for Deficit Syndrome (SDS). Additionally, newer instruments are in development-the Clinical Assessment Interview for Negative Symptoms (CAINS) and the Brief Negative Symptoms Scale (BNSS)-and are yielding promising results. This overview outlines these assessment tools so that clinicians can measure negative symptom severity and track treatment response for their patients with schizophrenia.
虽然目前针对阴性症状的有效治疗方法有限，但由于其对患者功能的影响，临床医生仍需要评估和监测这些症状。此外，记录患者的阴性症状可提供完整的临床记录，临床医生可据此做出系统、仔细的治疗决策。目前有多种用于评估精神分裂症阴性症状的工具，包括临床总体印象量表（CGI）、简明精神病评定量表（BPRS）、阳性和阴性症状量表（PANSS）、阴性症状评定量表（SANS）、16 项阴性症状评定量表（NSA-16）和缺陷综合征量表（SDS）。此外，还有一些新的工具正在开发中，如临床阴性症状评估访谈（CAINS）和简短阴性症状量表（BNSS），并取得了有前景的结果。本文概述了这些评估工具，以便临床医生能够测量精神分裂症患者的阴性症状严重程度并跟踪其治疗反应。
